Dogwood Therapeutics(DWTX)
$1.08+0.02 (+1.89%)
DWTX
Dogwood Therapeutics financials statements
$1.08
At close:+0.02 (+1.89%)
Want to see DWTX full AI Analyst Report?
Dogwood Therapeutics (DWTX) Ratios
271 Followers
Dogwood Therapeutics Ratios
DWTX's free cash flow for Q3 2026 was $-4.64M. For the 2026 fiscal year, DWTX's free cash flow was increased by $6.00 and operating cash flow was $-4.64M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.76 | 5.21 | 11.62 | 8.02 | 12.37 |
| Quick Ratio | 2.76 | 5.21 | 11.62 | 8.02 | 12.37 |
| Cash Ratio | 2.13 | 4.67 | 9.25 | 6.74 | 10.98 |
| Solvency Ratio | -2.24 | -0.41 | -14.77 | -11.74 | -12.51 |
| Operating Cash Flow Ratio | -5.11 | -2.77 | -13.58 | -10.99 | -12.30 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -176.89 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -6.84M | $ -13.48M | $ 3.81M | $ 7.33M | $ 14.50M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.17 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.24 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.20 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.19 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.20 | 1.47 | 1.09 | 1.14 | 1.09 |
| Debt Service Coverage Ratio | 0.00 | -86.30 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | -132.63 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 6.03 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.02 | 15.25 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.19 | -0.06 | 0.61 | 0.57 | 0.90 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.65% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 121.70% | 101.01% | 97.23% | 99.45% | 102.04% |
| Return on Assets (ROA) | -37.99% | -13.10% | -127.14% | -146.33% | -101.16% |
| Return on Equity (ROE) | -45.74% | -19.21% | -139.12% | -167.17% | -110.06% |
| Return on Capital Employed (ROCE) | -32.11% | -13.42% | -143.08% | -168.09% | -107.86% |
| Return on Invested Capital (ROIC) | -32.09% | -13.40% | -143.08% | -168.09% | -107.86% |
| Return on Tangible Assets | -389.95% | -73.57% | -127.14% | -146.33% | -101.16% |
| Earnings Yield | -100.18% | -482.56% | -49.04% | -468.81% | -37.46% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.90 | -8.55 | -6.48 | -25.90 | -47.09 |
| Free Cash Flow Per Share | -1.90 | -8.55 | -6.48 | -25.90 | -47.09 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -1758161.00 | 0.00 | -3822599.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | -1758161.00 | 0.00 | -3822599.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -96.05 | -0.56 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -45.67% | -343.50% | -45.10% | -438.95% | -36.82% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.96 | -0.21 | -2.04 | -0.21 | -2.67 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.46 | 0.04 | 2.84 | 0.36 | 2.94 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.19 | -0.29 | -2.22 | -0.23 | -2.72 |
| Price-to-Operating Cash Flow Ratio | -2.19 | -0.29 | -2.22 | -0.23 | -2.72 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -0.00 | 0.03 | 0.01 | 0.30 |
| Enterprise Value Multiple | -0.82 | -0.27 | -1.37 | 0.36 | -1.83 |
| Enterprise Value | 27.83M | 3.30M | 7.48M | -4.42M | 28.60M |
| EV to EBITDA | -0.82 | -0.27 | -1.37 | 0.36 | -1.83 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -1.78 | -0.38 | -1.54 | 0.39 | -1.82 |
| EV to Operating Cash Flow | -1.78 | -0.38 | -1.54 | 0.39 | -1.82 |
| Tangible Book Value Per Share | -0.79 | -12.88 | 5.07 | 16.55 | 43.52 |
| Shareholders’ Equity Per Share | 9.11 | 62.54 | 5.07 | 16.55 | 43.52 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -4.17 | -12.02 | -7.05 | -27.66 | -47.90 |
| Tax Burden | 1.01 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.01 | 0.97 | 0.99 | 1.02 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.46 | 0.71 | 0.92 | 0.94 | 0.98 |
Currency in USD

